https://pubmed.ncbi.nlm.nih.gov/38113736

The study finds that TFAM, a mitochondrial transcription factor, can be used as a new therapeutic target to reduce cadmium-induced lipid accumulation in the liver by regulating intercellular lipid droplet transfer.